292 related articles for article (PubMed ID: 12058090)
1. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study.
Pfeifer LA; White LR; Ross GW; Petrovitch H; Launer LJ
Neurology; 2002 Jun; 58(11):1629-34. PubMed ID: 12058090
[TBL] [Abstract][Full Text] [Related]
2. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.
Strozyk D; Blennow K; White LR; Launer LJ
Neurology; 2003 Feb; 60(4):652-6. PubMed ID: 12601108
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
Ringman JM; Sachs MC; Zhou Y; Monsell SE; Saver JL; Vinters HV
JAMA Neurol; 2014 Jul; 71(7):878-83. PubMed ID: 24797962
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
5. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
[TBL] [Abstract][Full Text] [Related]
6. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline.
Thal DR; Ghebremedhin E; Orantes M; Wiestler OD
J Neuropathol Exp Neurol; 2003 Dec; 62(12):1287-301. PubMed ID: 14692704
[TBL] [Abstract][Full Text] [Related]
7. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
8. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
9. Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample.
Paradela RS; Justo AFO; Paes VR; Leite REP; Pasqualucci CA; Grinberg LT; Naslavsky MS; Zatz M; Nitrini R; Jacob-Filho W; Suemoto CK
Acta Neuropathol Commun; 2023 Dec; 11(1):205. PubMed ID: 38115150
[TBL] [Abstract][Full Text] [Related]
10. Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study.
Attems J; Lauda F; Jellinger KA
J Neurol; 2008 Jan; 255(1):70-6. PubMed ID: 18202817
[TBL] [Abstract][Full Text] [Related]
11. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes.
Brenowitz WD; Nelson PT; Besser LM; Heller KB; Kukull WA
Neurobiol Aging; 2015 Oct; 36(10):2702-8. PubMed ID: 26239176
[TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.
Boyle PA; Yu L; Nag S; Leurgans S; Wilson RS; Bennett DA; Schneider JA
Neurology; 2015 Dec; 85(22):1930-6. PubMed ID: 26537052
[TBL] [Abstract][Full Text] [Related]
13. APOE and cerebral amyloid angiopathy in the elderly.
Love S; Nicoll JA; Hughes A; Wilcock GK
Neuroreport; 2003 Aug; 14(11):1535-6. PubMed ID: 12960780
[TBL] [Abstract][Full Text] [Related]
14. Cerebral amyloid angiopathy pathology and cognitive domains in older persons.
Arvanitakis Z; Leurgans SE; Wang Z; Wilson RS; Bennett DA; Schneider JA
Ann Neurol; 2011 Feb; 69(2):320-7. PubMed ID: 21387377
[TBL] [Abstract][Full Text] [Related]
15. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
[TBL] [Abstract][Full Text] [Related]
16. Cerebral amyloid angiopathy and dementia.
Tian J; Shi J; Mann DM
Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
[TBL] [Abstract][Full Text] [Related]
17. Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.
Hecht M; Krämer LM; von Arnim CAF; Otto M; Thal DR
Acta Neuropathol; 2018 May; 135(5):681-694. PubMed ID: 29574591
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for cerebral amyloid angiopathy in the elderly.
Yamada M
Ann N Y Acad Sci; 2002 Nov; 977():37-44. PubMed ID: 12480732
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
20. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
